Climax Professorship of Clinical Therapeutics (182810)

The post offers an outstanding opportunity for a high calibre clinical pharmacologist from academia and industry to join an established and growing environment aimed at more rapidly translating research and novel therapeutics into patient benefit. The Climax Professor will provide leadership in research and training in the area of accelerated drug development. Their work will focus on early phase experimental medicine with a primary aim of developing new safe accelerated drug development pathways, with new drugs reaching people sooner, making future drug development more cost effective and subsequently more affordable to more global healthcare systems. The successful candidate will provide internationally leading research activity, establishing a substantial, externally funded group and secure long-term funding for research and development in this field.

 

You will have evidence of distinction in leadership and of international distinction in clinical therapeutic research. You will possess a proven track record of delivery in clinical therapeutics and trial design, within or associated with industry, and have evidence of a major long-term track-record of raising substantial research and development funds via research funding bodies, or accessing such funding from within research and development funding in the pharmaceutical/biotechnology industry. You will have demonstrable experience and interest in teaching, as well as interests that are synergistic with the existing strengths of both the Department and the College.

 

For details about how to apply, including the job description and selection criteria, please see the further particulars (below). Queries about the post should be addressed to Professor Jonathan Rees, Head of Department and Director of the Botnar Institute, jonathan.rees@ndorms.ox.ac.uk.

 

The closing date for applications is 12 noon UK time on Thursday 11 December 2025. Interviews will take place in Oxford on 2 February 2026.